Mold Toxin and Copper Together Devastate Gut Cells at Low Doses
Common grain contaminant DON and dietary copper combine synergistically to damage intestinal barriers via mitochondrial oxidative stress.
Summary
Researchers discovered that deoxynivalenol (DON), a mold toxin widespread in grains, and copper (Cu), an essential trace mineral, synergistically damage intestinal cells even at individually non-toxic low doses. Using pig intestinal cells and mouse intestinal organoids, the team showed combined exposure disrupts the gut barrier, triggers both apoptosis and ferroptosis (iron-dependent cell death), and impairs intestinal organoid growth. The damage was driven by mitochondrial reactive oxygen species (mtROS) accumulation, disrupted membrane potential, and suppressed mitochondrial antioxidant defenses. Critically, pretreating cells with MitoQ, a mitochondria-targeted antioxidant, substantially reversed the damage, pointing to mitochondrial oxidative stress as the central mechanism. These findings raise important concerns about co-exposure to food contaminants and essential minerals in everyday diets.
Detailed Summary
Deoxynivalenol (DON) is one of the most prevalent mycotoxins globally, contaminating wheat, corn, and other staple grains. Copper is an essential trace element found in food and widely supplemented in animal feed. While each is studied independently, their combined effects on gut health had not been well characterized — until now.
Researchers at South China Agricultural University used two complementary models — IPEC-J2 pig intestinal epithelial cells and mouse intestinal organoids — to test what happens when DON and copper are combined at low, individually sub-toxic doses. The combination produced a striking synergistic toxic effect, significantly disrupting the intestinal barrier and suppressing organoid development far beyond what either agent caused alone.
Mechanistically, DON + Cu co-exposure altered expression of proteins regulating apoptosis (programmed cell death) and ferroptosis (a form of oxidative, iron-dependent cell death). Both cell death pathways were activated in tandem. The root cause appeared to be mitochondrial dysfunction: combined exposure drove excessive mitochondrial reactive oxygen species (mtROS), disrupted mitochondrial membrane potential (MMP) and mitochondrial permeability transition pores (mPTP), and suppressed mitochondrial antioxidant proteins.
Crucially, pretreatment with MitoQ — a well-characterized mitochondria-targeted antioxidant — effectively rescued cells from this damage, reducing both apoptosis and ferroptosis. This confirms mtROS accumulation as a primary driver rather than a secondary consequence.
For human health, these findings are relevant beyond livestock. Humans are routinely exposed to DON through grain-based foods and to copper through diet, water pipes, and supplements. The synergistic intestinal toxicity at low doses suggests current individual safety thresholds may not adequately protect against combined exposures. Further in vivo human-relevant studies are needed to determine real-world risk.
Key Findings
- Low doses of DON and copper together synergistically damage intestinal cells beyond the effect of either alone.
- Co-exposure activates both apoptosis and ferroptosis in intestinal organoids and epithelial cells.
- Mitochondrial ROS accumulation and disrupted membrane potential drive the combined intestinal toxicity.
- MitoQ, a mitochondria-targeted antioxidant, effectively reversed DON + Cu-induced gut cell damage.
- Combined exposure significantly inhibited intestinal organoid development, indicating broader gut dysfunction.
Methodology
The study used IPEC-J2 pig intestinal epithelial cells and mouse intestinal organoids as dual in vitro models. Synergistic toxicity was assessed via cell viability, barrier integrity, organoid growth, and protein-level analysis of apoptosis and ferroptosis markers. MitoQ pretreatment was used to confirm the mechanistic role of mitochondrial ROS.
Study Limitations
The study relied entirely on in vitro cell and organoid models, which may not fully replicate complex human gut physiology and microbiome interactions. Doses used may not precisely reflect real-world human co-exposure scenarios. Long-term chronic exposure effects were not assessed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: